Opko Health News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

07.10.24	NextPlat Announces Expansion Of E-commerce Distribution Greement With OPKO Health (RTTNews)
25.09.24	Entera Bio, OPKO Health Announce Positive Results For Oxyntomodulin Animal Models Against Obesity (RTTNews)
18.07.24	OPKO Health Board Approves Share Repurchase Of Up To $100 Mln (RTTNews)
28.03.24	Labcorp To Acquire Select Assets Of BioReference Health - Quick Facts (RTTNews)
28.11.23	BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing (PR Newswire)
07.11.23	BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™ (PR Newswire)
07.11.23	BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™ (PR Newswire)
12.09.23	Entera Collaborates With OPKO To Develop Oral Peptide Tablets For Obesity, Intestinal Malabsorption (RTTNews)
28.06.23	Pfizer Says Its NGENLA Gets FDA Approval To Treat Pediatric Growth Hormone Deficiency (RTTNews)
09.02.23	BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings (PR Newswire)
16.03.22	GeneDx Announces Discovery of 200 New and Expanded Genetic Conditions (PR Newswire)
01.03.22	Saol Therapeutics and GeneDx, Inc. Collaborate to Detect Patients with Rare Mitochondrial Disease (PR Newswire)
24.01.22	Pre-market Movers: BTBD, RETO, KSS, BON, PT… (RTTNews)
21.01.22	OPKO Health Tanks 10% After FDA Issues Complete Response Letter For Somatrogon (RTTNews)
27.12.21	Biotech Stocks Facing FDA Decision In January 2022 (RTTNews)
23.12.21	OPKO Announces Positive Results From Phase 2 Trial Of Rayaldee On Symptomatic COVID-19 Treatment (RTTNews)
29.11.21	BioReference Laboratories Announces Readiness for COVID-19 Testing if the Omicron COVID-19 Variant Emerges in The U.S. (PR Newswire)
27.09.21	Pre-market Movers: PHCF, PALT, BBIG, USEG, SNTG… (RTTNews)
21.09.21	GeneDx Announces the Sequencing of More Than 300,000 Clinical Patient Exomes (PR Newswire)
16.08.21	BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business (PR Newswire)
22.06.21	BioReference Laboratories Announces First COVID-19 Testing Program for Cruise Industry (PR Newswire)
26.02.21	Pfizer Says EMA Accepted Marketing Authorization Application For Growth Hormone Somatrogon (RTTNews)
04.01.21	Pfizer, OPKO: FDA To Review BLA For Somatrogon To Treat Patients With Growth Hormone Deficiency (RTTNews)
01.12.20	Pre-market Movers In Healthcare Sector: Moderna, ONTX, CRBP, GENE, OPK… (RTTNews)
24.09.20	Pre-market Movers In Healthcare Sector: BIOL, OTIC, ANPC, CEMI, LPCN, NAOV... (RTTNews)
21.07.20	Pre-market Movers In Healthcare Sector: IMRN, ABUS, IBIO, OPK, ONTX... (RTTNews)
13.03.20	Stock Alert: OPKO's BioReference Labs Offers Testing For COVID-19; Stock Up 45% (RTTNews)
06.03.20	Stock Alert: OPKO Health Shares Soar 32% In Pre-Market (RTTNews)
07.10.19	5 Healthcare Stocks Facing Key Catalysts In Q4, 2019 (RTTNews)
01.02.19	AVEO Crashes, FDA Approves 1st Generic Of ADVAIR DISKUS, 'Tis Advantage TTNP (RTTNews)
13.11.18	OPK To Report Data In Q1, EIDX Cheers Investors, Busy Year Ahead For VRCA (RTTNews)
12.09.18	FOMX Soars On Acne Trial Data, GLPG Abuzz, ACRX To Face FDA Panel In Oct. (RTTNews)
05.09.18	BCRX At Its Zenith, CRON Walks The Walk, TSRO To Report Data In Nov. (RTTNews)
21.05.18	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OPKO Health, Inc. - OPK (PR Newswire)
10.05.18	OPK Up 36% In 5 Days, SLDB Sparkles, CERS Abuzz, ARWR Expects Data In Nov. (RTTNews)
19.01.18	A Rundown Of Dravet Syndrome Drugs In The Pipeline (RTTNews)
10.11.17	SAGE Goes Out On A High Note, MRNS Spirited, STAAR Shines, OPK Slumps (RTTNews)
02.08.17	Eloxx Pharmaceuticals Secures US$8 Million Investment from LSP, Increasing Total Raised in Series C to US$38 million (PR Newswire)
27.07.17	Technical Reports on Biotech Equities -- Opko Health, Array BioPharma, Immunomedics, and TG Therapeutics (PR Newswire)
20.06.17	Breakfast Technical Briefing on Biotech Stocks -- Opko Health, Pain Therapeutics, Trevena, and Dynavax Technologies (PR Newswire)
22.05.17	MabVax Therapeutics Announces the Closing of its $4.1 Million Public Offering (PR Newswire)
20.03.17	Biotech Stocks Under Scanner -- MannKind, Opko Health, Celgene, and Array BioPharma (PR Newswire)
03.02.17	Biotech Stocks Under Scanner -- Mast Therapeutics, MannKind, Celgene, and Opko Health (PR Newswire)
29.12.16	Biotech Stocks Facing FDA Decision In January (RTTNews)
21.12.16	RXi Pharmaceuticals Announces Closing of $11.5 Million Underwritten Public Offering and Full Exercise of Over-allotment Option (PR Newswire)
13.12.16	Covered Call reports for Alexion Pharmaceuticals, Cornerstone OnDemand, Inc., Northrop Grumman Corporation, Opko Health and Lockheed Martin Corporation include trade ideas that offer returns of 23%... (PR Newswire)
12.12.16	Biotech Stocks Under Review -- Mast Therapeutics, Array BioPharma, Opko Health, and Merrimack Pharma (PR Newswire)
06.12.16	Amazon.com trade offers a 6.05% return in 74 days, or find similar option trades on Intercept Pharmaceuticals, Energous Corporation, Opko Health, and 3D Systems (PR Newswire)
25.11.16	JUNO Implodes As ROCKET Is Put On Hold Again, LLY's Expedition Fails (RTTNews)
06.09.16	OPKO to Present Long-acting Human Growth Hormone (hGH-CTP) Phase 2 Pediatric Growth Hormone Deficiency Data at the 55th Annual Meeting of the European Society for Paediatric Endocrinology (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

CieFinRichemont	121.95	2.87 %	K V
Lonza Grp	530.60	1.76 %	K V
UBS Group	28.52	0.78 %	K V
Part Grp Hldg	1’273.00	0.75 %	K V
Nestle	76.56	0.74 %	K V
Zurich Insur Gr	550.20	-0.51 %	K V
Givaudan	3’913.00	-0.51 %	K V
Sonova Hldg	310.20	-0.61 %	K V
Swiss Life Hldg	726.40	-0.98 %	K V
Novartis	92.46	-1.30 %	K V

Nachrichten zu Opko Health IncShs

Aktien Top/Flop

Meistgelesene Nachrichten